119795-57-2 Usage
Uses
Used in Pharmaceutical Industry:
1-Chloro-4-(3-iodopropoxy)benzene is used as a chemical intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and improving the efficacy and safety of existing medications.
Used in Agrochemical Industry:
In the agrochemical sector, 1-Chloro-4-(3-iodopropoxy)benzene is employed as a building block in the creation of pesticides and other agricultural chemicals, enhancing crop protection and yield.
Used in Specialty Chemicals Production:
1-Chloro-4-(3-iodopropoxy)benzene is utilized as an intermediate in the production of specialty chemicals, which are essential for various industrial applications, including the manufacturing of dyes, plastics, and coatings.
Check Digit Verification of cas no
The CAS Registry Mumber 119795-57-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,9,7,9 and 5 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 119795-57:
(8*1)+(7*1)+(6*9)+(5*7)+(4*9)+(3*5)+(2*5)+(1*7)=172
172 % 10 = 2
So 119795-57-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H10ClIO/c10-8-2-4-9(5-3-8)12-7-1-6-11/h2-5H,1,6-7H2
119795-57-2Relevant academic research and scientific papers
Photoinduced Copper-Catalyzed Coupling of Terminal Alkynes and Alkyl Iodides
Hazra, Avijit,Lee, Mitchell T.,Chiu, Justin F.,Lalic, Gojko
supporting information, p. 5492 - 5496 (2018/04/19)
We have developed a photoinduced copper-catalyzed alkylation of terminal alkynes with primary, secondary, or tertiary alkyl iodides as electrophiles. The reaction has a broad substrate scope and can be successfully performed in the presence of ester, nitr
2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesis
Hammond,Kopka,Zambias,Caldwell,Boger,Baker,Bach,Luell,MacIntyre
, p. 1006 - 1020 (2007/10/02)
The enzymes that catalyze the oxidative metabolism of arachidonic acid have provided fertile ground for the development of useful therapeutic agents for nearly a quarter century. Inhibitors of the enzyme cyclooxygenase prevent the formation of the prostag